rotem® delta analyzer  (TEM International)

Journal: International Journal of Laboratory Hematology

Article Title: Thromboelastometry ( ROTEM ) Assessing Hypercoagulability in Patients Referred for Thrombophilia Screening

doi: 10.1111/ijlh.14443

Figure Lengend Snippet: ROTEM parameters in the studied population. Graphical representation of ROTEM parameters INTEM and EXTEM including clot formation time (CFT), alpha angle (AA), and maximum clot firmness (MCF) among patients with and without a history of VTE. Results highlight significant differences in coagulation profiles between groups.

Article Snippet: Coagulability was assessed using the Delta ROTEM thromboelastometry analyzer within 15 min according to the manufacturer's instructions (Munich, Germany).

Techniques: Coagulation

Journal: International Journal of Laboratory Hematology

Article Title: Thromboelastometry ( ROTEM ) Assessing Hypercoagulability in Patients Referred for Thrombophilia Screening

doi: 10.1111/ijlh.14443

Figure Lengend Snippet: ROTEM: receiver operating curve. MCF , maximum clot firmness. Receiver operating characteristic ( ROC ) curves for ROTEM parameter. Clot formation time, alpha angle, and MCF assessed using EXTEM and INTEM assays in patients referred for thrombophilia screening. The area under the curve ( AUC ) values are displayed to evaluate the diagnostic ability of these parameters to discriminate VTE occurrence. The blue line represents patient data and the green line represents the line of zero predictive ability.

Article Snippet: Coagulability was assessed using the Delta ROTEM thromboelastometry analyzer within 15 min according to the manufacturer's instructions (Munich, Germany).

Techniques: Diagnostic Assay

Journal: Oxidative Medicine and Cellular Longevity

Article Title: Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot

doi: 10.1155/2019/9084643

Figure Lengend Snippet: Rats which underwent antithrombotic agent aspirin (10 mg/kg intragastrically, once daily for three days) received immediately thereafter BPC 157 (10 μ g/kg intragastrically, once daily for three days) (white bars) or an equal volume of saline (5 ml/kg, intragastrically, once daily for three days) (gray bars); they were sacrificed at 2 h after the last application. Viscoelastic properties of the blood were assessed using modified rotational thromboelastometry (TEM) on ROTEM® delta analyzer (Tem International GmbH, Germany). Typical parameters obtained are clotting time (CT), the time from the beginning of measurement until the clot starts to form; clot formation time (CFT), the time needed for the clot to reach an amplitude of 20 mm; alpha-angle, angle of tangent at 2 mm amplitude; maximum clot firmness (MCF), the maximum amplitude of the curve during 60 minutes of measurement; Ly30, clot lysis at 30 minutes; and maximum lysis (ML) which describes the percentage of the maximum lost clot firmness relative to MCF. We analyzed the external pathway with tissue factor (EXTEM), an intrinsic pathway with ellagic acid (INTEM), or without platelet contribution with cytochalasin D (FIBTEM). After 60 minutes, CT, CFT, alpha-angle, MCF, Ly30, and ML were recorded. P > 0.05, vs. control.

Article Snippet: Viscoelastic properties of the blood were assessed using modified rotational thromboelastometry (TEM) on ROTEM® delta analyzer (Tem International GmbH, Germany).

Techniques: Modification, Coagulation, Lysis, FIBTEM Assay

Journal: Oxidative Medicine and Cellular Longevity

Article Title: Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot

doi: 10.1155/2019/9084643

Figure Lengend Snippet: Rats which underwent antithrombotic agent cilostazol (10 mg/kg intragastrically, once daily for three days) received immediately thereafter BPC 157 (10 μ g/kg intragastrically, once daily for three days) (white bars) or an equal volume of saline (5 ml/kg, intragastrically, once daily for three days) (gray bars); they were sacrificed at 2 h after the last application. Viscoelastic properties of the blood were assessed using modified rotational thromboelastometry (TEM) on ROTEM® delta analyzer (Tem International GmbH, Germany). Typical parameters obtained are clotting time (CT), the time from the beginning of measurement until the clot starts to form; clot formation time (CFT), the time needed for the clot to reach an amplitude of 20 mm; alpha-angle, angle of tangent at 2 mm amplitude; maximum clot firmness (MCF), the maximum amplitude of the curve during 60 minutes of measurement; Ly30, clot lysis at 30 minutes; and maximum lysis (ML) which describes the percentage of the maximum lost clot firmness relative to MCF. We analyzed external pathway with tissue factor (EXTEM), an intrinsic pathway with ellagic acid (INTEM), or without platelet contribution with cytochalasin D (FIBTEM). After 60 minutes CT, CFT, alpha-angle, MCF, Ly30, and ML were recorded. P > 0.05, vs. control.

Article Snippet: Viscoelastic properties of the blood were assessed using modified rotational thromboelastometry (TEM) on ROTEM® delta analyzer (Tem International GmbH, Germany).

Techniques: Modification, Coagulation, Lysis, FIBTEM Assay